References
- Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Inl J Epidemiol 1988;17:514–9.
- Helweg-Larsen K. The validity of the mortality statistics in Greenland with special reference to ischemic heart disease. Arc1 Med Res 1984;38:43–5.
- Bjerregaard P. Validity of Greenlandic mortality statistics. Arcf Med Res 1986;42:18–24.
- Bjerregaard P. Causes of death in Greenland 1968-85. Arc1 Med Res 1988;47:105–23.
- Bjerregaard P, Johansen LG. Mortality pattern in Greenland. Arct Med Res 1987;46:71–7.
- Mitler MM, Hajdukovic RM, Shafor R, Hahn PM, Kripke DF. When people die. Cause of death versus time of death. Am J Med 1987;82:266–74.
- Mulcahy D, Keegan J, Cunningham D, et al. Circadian variations of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; 11:755–8.
- Rocco M, Barry J, Cambell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395–400.
- Muller JE, Stone PH, Tun ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N EnglJMed 1985;313:1315–22.
- Gram J, Jespersen J. A selective depression of tissue plasrninogen activator (t-PA) activity in euglobulins characterizes a risk group among survivors of acute myocardial infarction. Thromb Haemost 1987;57:137–9.
- Gram J, Jespersen J, Kluft C, Rijken DC. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial infarction. Acta Med Scand 1987;221:149–53.
- Hamsten A, de Faire M, Walldius G, et al. Plasminogen activator inhibitor in plasma. Risk factor for recurrent myocardial infarction. Lancet 1987;11:3–9.
- Jespersen J. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity. Thromb Haemost 1986;56:183–8.
- Kluft C, Jie AFH, Rijken DC, Verheijen JH. Daytime fluctuationsin blood of tissue type plasminogen activator (t-PA) and its fast acting inhibitor PAI- 1. Thromb Huemost 1988;59:329–32.
- Grimaudo V, Hauert J, Bachmann F, Kruithoff EKO. Diurnal variation of the fibrinolytic system. Thromb Haemost 1988;59:495–9.
- Andreotti F, Davies GJ, Hackett D, et al. Circadian variation of fibrinolytic factors in normal human plasma. Fibrinolysis 1988;2(suppl 2):90-2.
- Johansen LG, Gram J, Kluft C, Jespersen J. Circadian variations of extrinsic fibrinolytic components in blood from Eskimos. Fibrinolysis 1990;4:35–9.
- Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J. The effect of n-6 and n-3 polyunsaturated fatty acids on haemostasis, blood lipids and blood pressure. Thromb Haemost 1983;50:543–6.
- Bjerregaard P, Dyerberg J. Fish oil and ischaemic heart disease in Greenland. Lancet 1988;11:514.
- Jespersen J, Knudsen LH, Sidelmann J. The use of evacuated glass tubes for collection of blood samples for fibrinolytic assays. Thromb Res 1982;25:173–6.
- Verheijen JH, Mullaart E, Chang GTG, Kluft C. A simple sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Huemost 1982;48:266–9.
- Gram J, Jespersen J. A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasma. Fibrinolysis 1987; 13–7.